The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Blog I

Oncology Teams Set to Grow with Eli Lilly and The Chase Group Partnership

November 26, 2018
Lilly Oncology is known for its exciting pipeline across multiple tumor types and dedication to addressing the unmet needs of people living with cancer. Their… Continue Reading →

The Chase Group Secures the Vice President, US and Global Medical Affairs for Eli Lilly

November 26, 2018
The Chase Group is pleased to announce the successful completion of the Vice President, US and Global Medical Affairs at Eli Lilly. The new Vice… Continue Reading →

Aeglea BioTherapeutics (NASDAQ: AGLE) Partners with The Chase Group to Build Clinical Development Team for Rapidly Expanding Genetic Rare Disease Portfolio

November 9, 2018
As a leader in engineering human enzymes to address significant unmet medical needs in rare genetic diseases and cancer, Aeglea BioTherapeutics is committed to using… Continue Reading →

International Next-Generation Immunotherapy Developer Partners with The Chase Group to Build New Executive Team

October 31, 2018
The Chase Group is pleased to announce our recent partnership and executive search engagement with the international biopharmaceutical company, Immunovative Therapies, Ltd. (ITL), currently headquartered… Continue Reading →

Ionis Pharmaceuticals Secures Associate Director, Investor Relations

October 22, 2018
The Chase Group is pleased to announce our latest placement for Ionis Pharmaceuticals. Due to exciting organizational growth, Ionis welcomes a new Associate Director, Investor… Continue Reading →

The Chase Group Secures the Vice President, Global Head of Data Sciences for Genmab

October 4, 2018
The Chase Group is pleased to announce the successful completion of the Vice President, Global Head of Data Sciences search at Genmab. A scientist with… Continue Reading →

Pivotal Hires Delivered At Pivotal Time For Immuno-Oncology Company

October 1, 2018
The pipeline of rare disease drugs in development at Ionis Pharmaceuticals has grown significantly in the last five years. And, with a robust pipeline combined with a commercialization strategy, including complex partnerships involving complicated deal structures, financial leadership roles are key to managing the process and bringing life-changing therapies to market. When Ionis needs to fill critical leadership roles, The Chase Group delivers outstanding people who are committed to the mission and the culture. Continue Reading →

Continued growth at Genmab leads back to The Chase Group in search for a Director/Senior Director, Drug Safety Physician

August 30, 2018
As Genmab continues its expansion into full product development, the need for high caliber talent is essential in executing their mission to create and develop… Continue Reading →

Esteemed Allen Institute Partners with The Chase Group for Cutting-Edge Executive Search

August 20, 2018
The Chase Group is pleased to announce our recent partnership and executive search engagement with the highly-respected Allen Institute in Seattle, Washington. Devoted to unlocking… Continue Reading →

A Successful Placement at Eisai, Inc.

August 1, 2018
The Chase Group is pleased to announce the successful completion of the Director, Clinical Research, Neuroscience at Eisai Inc. The successful candidate is a Board… Continue Reading →
© Copyright 1993-2018 The Chase Group; All Rights Reserved.